Status:
TERMINATED
Evaluation of an Anti-Shivering Protocol Cardiac Arrest
Lead Sponsor:
Methodist Health System
Conditions:
Cardiac Arrest
Eligibility:
All Genders
18+ years
Brief Summary
This will be a single center, retrospective, before-and-after, chart review of all patients undergoing TTM between June 1, 2017 and May 31, 2021 at MDMC. Initiation of the new TTM protocol occurred on...
Detailed Description
This will be a single center, retrospective, before-and-after, chart review of all patients undergoing TTM between June 1, 2017 and May 31, 2021 at MDMC. Initiation of the new TTM protocol occurred on...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Diagnosis of cardiac arrest
- Initiation of TTM via Arctic Sun® device
Exclusion
- Initiation of TTM \> 12 hours after cardiac arrest
- Receiving NMBs for an indication other than TTM
- Early termination of TTM (less than 24 hours)
Key Trial Info
Start Date :
September 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 9 2024
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT05264246
Start Date
September 15 2021
End Date
September 9 2024
Last Update
November 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Methodist Dallas Medical Center
Dallas, Texas, United States, 75203